| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 10/09/2002 | EP0882704B1 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives |
| 10/09/2002 | CN1373783A Polyalkoxylated superamides optionally functionalised, use as emulsifiers |
| 10/09/2002 | CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides |
| 10/08/2002 | US6462234 Process to prepare (2S)-2-(dipropylamino)-6-ethoxy-2, 3-dihydro-1H-indene-5-carboxamide |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6461643 Consists of at least one biologically- active agent; (b) at least one carrier comprising an acylated aldehyde of an amino acid, an acylated ketone of an amino acid, an acylated aldehyde of a peptide, an acylated ketone of a peptide |
| 10/08/2002 | CA2250066C Process for alkylating and smiles rearrangement of hydroxy aromatics |
| 10/08/2002 | CA2081766C Leukotriene b4 antagonists |
| 10/03/2002 | WO2002076921A1 Gallic acid derivatives and use for exploring endogenetic coagulation |
| 10/03/2002 | WO2002076918A1 NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT |
| 10/03/2002 | WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids |
| 10/03/2002 | US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 10/03/2002 | US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction |
| 10/03/2002 | US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders |
| 10/03/2002 | CA2410816A1 Nf-.kappa.b inhibitor containing substituted benzoic acid derivative as active ingredient |
| 10/03/2002 | CA2407779A1 Gallic acid derivatives and use for exploring endogenetic coagulation |
| 10/02/2002 | EP1245650A2 Low foam N,N'-dialkylmalamide wetting agents |
| 10/02/2002 | EP1245648A2 Low foam n,n'-dialkyltartaramide wetting agents |
| 10/02/2002 | EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 10/02/2002 | EP1245229A2 Methods and compositions for inhibition of angiogenesis |
| 10/01/2002 | US6458957 α,α-dibromo-α-chloro-acetophenones as synthons |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/26/2002 | WO2002074403A1 Process for obtaining an organic acid from an organic acid ammonium salt, an organic acid amide, or an alkylamine organic acid complex |
| 09/26/2002 | WO2002074402A1 Azeotropic distillation process for producing organic acids or organic acid amides |
| 09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137855 Universal supports for oligonucleotide synthesis |
| 09/26/2002 | US20020137775 Novel delta dicarbonyl compounds and methods for using the same |
| 09/26/2002 | CA2440987A1 Process for obtaining an organic acid from an organic acid ammonium salt, an organic acid amide, or an alkylamine organic acid complex |
| 09/26/2002 | CA2439883A1 Azeotropic distillation process for producing organic acids or organic acid amides |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | CN1371357A Aminobenzoic acid derivatives |
| 09/24/2002 | US6455701 Such as 4-((4'-tert-butyl-3'-(4?-trifluoromethyl)phenoxy) phenylethynyl)benzoic acid; side effect reduction |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/19/2002 | WO2002072857A1 Processes for enhanced production of pantothenate |
| 09/19/2002 | WO2002072553A1 Antiproliferative agents |
| 09/19/2002 | WO2002072083A1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2439895A1 Processes for enhanced production of pantothenate |
| 09/18/2002 | EP1240132A1 Adamantane derivatives |
| 09/18/2002 | EP1036059B1 Adamantane derivatives |
| 09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/17/2002 | US6452051 Process for the production of a condensation products of a carboxylic acid |
| 09/17/2002 | US6452044 Benzenedicarboxylic acid derivatives |
| 09/17/2002 | US6452012 3-phenyl-2,6-dioxopiperidin-3-ylpropionamide derivatives and method for preparing same |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | CA2158622C Cosmetic compositions containing a lipidic compound of ceramid type and a fatty peptide, and their uses |
| 09/17/2002 | CA2074352C Compositions and methods for inhibiting browning in foods |
| 09/12/2002 | WO2002070545A2 Siderophore analogues as tetra- or hexadentate iron chelators on the basis of amino acids or peptides, method for producing them and the use thereof |
| 09/12/2002 | WO2002070482A1 Process for producing optically active n-aryl-1-amino-2-propanol derivatives |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070463A1 Gelling agents or thickeners |
| 09/12/2002 | WO2002070438A2 Compositions for delivering bisphosphonates |
| 09/12/2002 | WO2002069937A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | WO2002055480A3 6-substituted indanoyl amino acid conjugates as mimics to the biological activity of coronatine |
| 09/12/2002 | US20020128451 Phthalamide-lanthanide complexes for use as luminescent markers |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128231 Aryl-indane compounds |
| 09/12/2002 | US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | US20020127181 Antagonist diamidediphenolate compounds attached to a metal chelate and linking group; use as contrast agents for X-ray imaging and magnetic resonance imaging |
| 09/12/2002 | CA2439208A1 Process for producing optically active n-aryl-1-amino-2-propanol derivatives |
| 09/12/2002 | CA2438849A1 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP1237872A1 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/10/2002 | US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/10/2002 | US6448442 Contrast media |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002067761A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/06/2002 | CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/05/2002 | US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC |
| 09/05/2002 | DE10111164A1 New catechol derivatives derived from amino acids have siderophore activity and are useful as growth factors in bacterial cultures and as prodrugs for iron chelators |
| 09/05/2002 | DE10111161A1 Neue Siderophoranaloga als 4- oder 6-zähnige Eisenchelatoren auf der Basis von Aminosäuren oder Peptiden, Verfahren zu ihrer Herstellung und ihre Anwendung New Siderophoranaloga as 4- or 6-dentate iron chelators based on amino acids or peptides, process for their preparation and their use |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1235790A2 Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives |
| 09/04/2002 | EP1175390A4 Disodium salts, monohydrates, and ethanol solvates |
| 09/04/2002 | EP1149066A4 Method of preparing alkylated salicylamides |
| 09/03/2002 | US6444850 Fungicidial compounds having a fluorovinyloxphyenyl moiety and process for the preparation thereof |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002002520A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |